Schizophrenia in late life: emerging issues

Schizophrenia in late life is emerging as a major public health concern worldwide. We discuss several areas of research and clinical care that are particularly pertinent to older persons with schizophrenia, including the public health challenge and the cost of care. We then discuss clinical issues r...

Full description

Saved in:
Bibliographic Details
Published in:Dialogues in clinical neuroscience 2006, Vol.8 (1), p.45-52
Main Authors: Folsom, David P., Lebowitz, Barry D., Lindamer, Laurie A., Palmer, Barton W., Patterson, Thomas L., Jeste, Dilip V.
Format: Article
Language:English
Subjects:
Age of Onset
Aged
Aged, 80 and over
Antipsychotic Agents - therapeutic use
Clinical Research
cognition
comorbidity
geriatric
Geriatrics
Health Services for the Aged
Humans
schizophrenia
Schizophrenia - epidemiology
Schizophrenia - physiopathology
Schizophrenia - therapy
treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Schizophrenia in late life is emerging as a major public health concern worldwide. We discuss several areas of research and clinical care that are particularly pertinent to older persons with schizophrenia, including the public health challenge and the cost of care. We then discuss clinical issues relevant to late-life schizophrenia (course of illness and cognition), medical care and comorbidity in older psychiatric patients (general and illness-related), and treatment concerns related to the use of atypical antipsychotics in older persons with psychosis (efficacy and side effects). Clinical care for this ever-increasing segment of our population requires special consideration of the unique characteristics of older persons with schizophrenia.
ISSN:1294-8322
1958-5969
1958-5969
DOI:10.31887/DCNS.2006.8.1/dfolsom